Nucor Corp. (NUE)

64.36
1.30 2.10
NYSE : Non-Energy Minerals
Prev Close 63.05
Open 63.50
Day Low/High 63.39 / 64.80
52 Wk Low/High 53.34 / 70.48
Volume 1.31M
Avg Volume 2.23M
Exchange NYSE
Shares Outstanding 316.34M
Market Cap 19.80B
EPS 4.10
P/E Ratio 11.99
Div & Yield 1.52 (2.39%)

Latest News

We'd Hoped That Nucor's Guidance Would Have Been Better

The company is printing money right now but if the results aren't enough to calm long-term demand and cyclicality concerns, then we ask ourselves, when will it?

Jim's Daily Rundown

Jim discusses PayPal, Square, Disney and much more.

Nucor Announces Guidance For Its Third Quarter Earnings

Nucor Announces Guidance For Its Third Quarter Earnings

CHARLOTTE, N.C.

PPI Declined in August

The Producer Price Index measures price changes from producers' perspectives.

Weekly Roundup

Investors wrapped up a volatile week on Wall Street.

Nucor Announces Plans To Expand Sheet Mill In Kentucky

Nucor Announces Plans To Expand Sheet Mill In Kentucky

CHARLOTTE, N.C.

We’re Unlikely to See the Market Correct on Tuesday

The group rotation seems to me to continue to be the theme.

Weekly Roundup

Markets pressed higher this week as the U.S. and Mexico came to an agreement on trade.

U.S. Steel's Stock Is Set to Collapse Again: Analyst

U.S. Steel's Stock Is Set to Collapse Again: Analyst

Steel stocks have peaked, Vertical Group's Gordon Johnson argued Friday, and Trump may undo the rally by exempting countries from steel tariffs as George Bush did in 2002.

Weekly Roundup

Markets pushed higher this week with the S&P 500 hitting a record high and showing resilience through several politically volatile events.

Nuevolution Discloses The Identity Of Its "Cytokine X" Program Being Interleukin IL-17A And Initiates Promotion Of Its Small Molecule IL-17A Inhibitor Program Targeting Inflammatory Diseases

Nuevolution Discloses The Identity Of Its "Cytokine X" Program Being Interleukin IL-17A And Initiates Promotion Of Its Small Molecule IL-17A Inhibitor Program Targeting Inflammatory Diseases

STOCKHOLM, Aug. 22, 2018 /PRNewswire/ -- Today, Nuevolution AB (publ) announced the identity of its "Cytokine X" program being a lead discovery program targeting inhibition of Interleukin IL-17A using small molecules.

Weekly Roundup

We heard earnings from portfolio holdings Nvidia and Nordstrom this week, with one report bullish and the other bearish.

Weekly Roundup

Markets end the week on a sour note.

What Redfin's CEO Told Wall Street Should Freak Out Bullish Investors

What Redfin's CEO Told Wall Street Should Freak Out Bullish Investors

The Tesla saga continues. A housing company's comments should scare you. Intel is hated by Wall Street. And, it may be a slow summer Friday, but TheStreet's newsroom is on fire with scoops and analysis.

Nucor's Chairman DiMicco Stands With Trump on Trade, Benefits From Protection

Nucor's Chairman DiMicco Stands With Trump on Trade, Benefits From Protection

Nucor Corp. Chairman Emeritus Dan DiMicco worked with Donald Trump's economic and trade team to help develop a four-prong strategy to boost America's productivity.

PPI Unchanged in July, Misses Expectations

The new PPI numbers come ahead of Friday's July Consumer Price Index (CPI) reading.

The Charts Can Clearly Show Where Nucor Breaks Out on the Topside

The Charts Can Clearly Show Where Nucor Breaks Out on the Topside

NUE has been in a three-year uptrend, so the major trend is up.

Forgive and Forget -- and Buy: Cramer's 'Mad Money' Recap (Monday 8/6/18)

Forgive and Forget -- and Buy: Cramer's 'Mad Money' Recap (Monday 8/6/18)

Jim Cramer says this market is clamoring for stocks that haven't moved -- yet.

Enbridge Energy, Lending Tree, U.S. Steel: 'Mad Money' Lightning Round

Enbridge Energy, Lending Tree, U.S. Steel: 'Mad Money' Lightning Round

Jim Cramer weighs in on Enbridge Energy, Lending Tree, U.S. Steel, Philip Morris, Opko Health, The Trade Desk, EPR Properties, Nokia.

Weekly Roundup

Markets edged higher in what was a busy week from both a political and economic perspective.

Analyst Favorites: Nucor Ranks As A Top Metals Pick

Analyst Favorites: Nucor Ranks As A Top Metals Pick

A study of analyst recommendations at the major brokerages shows that Nucor Corp. is the #11 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel Global Mining Titans Index, according to Metals Channel.

Trade Wars: Winners & Losers for Investors

Trade Wars: Winners & Losers for Investors

Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.

Weekly Roundup

An earnings heavy week also included progress on reducing trade tensions.

Signals From the Volatility Index: Cramer's 'Off the Charts'

Signals From the Volatility Index: Cramer's 'Off the Charts'

Mark Sebastian and Jim Cramer go over the VIX charts to see if the market is headed for another swoon.

Coca-Cola, World Wrestling Entertainment: 'Mad Money' Lightning Round

Coca-Cola, World Wrestling Entertainment: 'Mad Money' Lightning Round

Jim Cramer weighs in on World Wrestling Entertainment, Wolverine World Wide, Kraft Heinz, Royal Dutch Shell, Coca-Cola, Scotts Miracle-Gro, Columbia Financial.

Watch Out for Extreme Swings: Cramer's 'Mad Money' Recap (Tuesday 7/24/18)

Watch Out for Extreme Swings: Cramer's 'Mad Money' Recap (Tuesday 7/24/18)

The extremes have to be avoided, says Jim Cramer. Investors really need to figure out what's going on before they take any action.

TheStreet Quant Rating: B (Buy)